Headache rate and cost of care following lumbar puncture at a single tertiary care hospital
Citation Manager Formats
Make Comment
See Comments

Abstract
Background: American Academy of Neurology guidelines recommend the use of noncutting needles because of lower rates of headache following lumbar puncture in randomized trials. We sought to determine the rate of headache using cutting needles and the potential cost savings of switching to noncutting needles.
Methods: We retrospectively reviewed the charts of all patients who had a lumbar puncture in the outpatient neurology clinic at a single institution between January 2004 and December 2005. Outcome data included occurrence of headache, back pain, or epidural hematomas within 2 weeks of the procedure. Costs associated with the use of the current system were compared with the projected costs of switching to a noncutting needle system.
Results: A total of 274 patients underwent lumbar puncture (62% women, mean age 53 ± 17 years, average weight 178 ± 43 pounds). Of these, 38 (14%) had a post–lumbar puncture headache. Eight patients (3%) reported back pain. No patients had an epidural hematoma. Twelve patients were admitted for a total of 18 hospital days, mainly for headache. Predictors of headache were younger age and no prior aspirin use. The rate of headache associated with the noncutting needle according to published literature is 4%. The estimated cost savings would have been approximately $20,000 per year (or approximately $73 per person).
Conclusions: In this single-institution study, use of a noncutting needle would have potentially been associated with less adverse events and less cost. Further studies are warranted, including the possibility of premedication with aspirin.
J.L. Corning1 performed the first lumbar puncture (LP) in 1885 using sharpened bird quills. Quincke2 wrote about the technique of lumbar puncture and the study of the CSF in 1891. In 1898, Bier was the first to report a post–lumbar puncture headache (PLPH) after he and his colleagues underwent LP themselves and experienced headaches.3
The International Headache Society criteria for PLPH are as follows: 1) headache that worsens within 15 minutes after sitting or standing and improves within 15 minutes after lying down, with at least one of the following: neck stiffness, tinnitus, hypacusia, photophobia, nausea; 2) a dural puncture has been performed; 3) headache develops within 5 days of the dural puncture; and 4) headache resolves either spontaneously within 1 week or within 48 hours after effective treatment of the spinal fluid leak (usually by epidural blood patch).4
In 2000, the American Academy of Neurology (AAN) published an evidence-based guideline for the performance of lumbar puncture.5 Noting the varying definitions of PLPH and based on the best available evidence at the time of their review, the authors of the report recommended smaller needle sizes, bevel direction parallel to the dural fibers when using a cutting needle, and replacement of the stylet before withdrawal of the needle when using a noncutting needle. In 2005, an addendum was published recommending the use of a noncutting needle as a means of reducing PLPH.6
We sought to determine the rate of PLPH at a tertiary care hospital using standard 20-gauge cutting needles and the potential cost savings of switching to a noncutting needle.
METHODS
Standard protocol approvals, registrations, and patient consents.
The study was approved by the local ethics review board (IRB 4340).
Study design, setting, and patient population.
Using a list of patients who underwent lumbar puncture that is maintained by clinic staff, we performed a retrospective study of consecutive patients who underwent a lumbar puncture in the neurology outpatient clinic at Henry Ford Hospital between January 1, 2004, and December 31, 2005. All patients had lumbar punctures performed with a 20-gauge cutting needle and were recumbent for at least 60 minutes. Because this was a retrospective study, PLPH was defined as notification of a positional headache within 2 weeks of the procedure. Phone communications, outpatient visits, emergency department visits, and hospital admissions recorded in the hospital's electronic medical record within 2 weeks of the procedure were reviewed. Information that was collected included age, gender, and weight; history of aspirin, clopidogrel, dipyridamole, or warfarin use within 1 week of the procedure; occurrence of PLPH; treatments for PLPH including IV caffeine and blood patch; back pain; epidural hematoma; days of hospitalization if admitted; and whether a telephone encounter occurred within 2 weeks of the procedure.
Assessment of cost.
The cost of a noncutting needle kit was obtained from the manufacturer (Dyna Medical); the cost of a cutting needle kit was obtained from the hospital purchasing department; IV caffeine infusion cost was obtained from the hospital pharmacy administration; the cost of a blood patch was obtained from the department of anesthesiology. For patients who were hospitalized or admitted to a clinical decision unit, hospital costs for the admissions were obtained from the hospital revenue administration.
Statistical analysis.
Logistic regression analysis was used to determine which variables predicted PLPH. Univariate factors with a p value of less than 0.20 were entered into a multivariable logistic regression model for the predicting headaches. Theoretical cost comparisons between the use of a cutting and noncutting needle were based on cost information described above. Because all patients in this study had the procedure performed with a cutting needle, the rate of headache following a noncutting needle use was estimated from the AAN Therapeutics Committee report.6
RESULTS
Between January 1, 2004, and December 31, 2005, 274 patients underwent lumbar puncture. Baseline demographic information and medication use is listed in table 1. There were 169 women (62%), with mean age was 53 ± 17, and average weight of 178 ± 43 pounds. Within 1 week prior to the procedure, 60 (22%) were taking aspirin, 3 (1%) were taking aspirin/dipyridamole, 14 (5%) were taking clopidogrel, and 5 (2%) were taking warfarin. Of the 274 patients, 38 (14%) had a PLPH. IV caffeine was used in 11 (29%) and blood patches in 7 (18%) of the 38 patients with headache. Of the 7 patients who had a blood patch, 2 did not receive IV caffeine beforehand. Eight patients (3%) reported back pain. Twelve patients were admitted for a total of 18 hospital days (17 days for PLPH, 1 day for back pain). None of the patients had an epidural hematoma. Sixteen patients (6% of the total group) had a telephone encounter within 2 weeks of the lumbar puncture.
Univariate predictors of headache
Demographic and baseline factors that were associated with a PLPH were age and prior aspirin use (table 1). The odds of having a headache decreased by 5% for each 1-year increase in age. The odds of having a headache were 5.9 times greater for those who did not take aspirin. In the multivariable model, only age was a predictor of headache (table 2).
Multivariable predictors of headache
The cost of the noncutting needle kit was $10.25 per spinal needle plus $8.84 for a lumbar puncture kit. The cost of the cutting needle kit was $8.84 per kit. The cost of IV caffeine infusion was $2,475 for 500-mg dose ($297.90/60-mg vial). The cost for a blood patch was $1,500. Hospitalization in the neurology inpatient service was $1,209/day. The rate of headache associated with the a noncutting needle according to the AAN therapeutics guideline is 4%.6 Based on these costs and estimate, the total cost associated with the use of the cutting needle over 2 years (including kit and care of the patient with headache) was $65,536 (table 3). The estimated cost of having used a noncutting needle was $22,910. The estimated cost savings by using a noncutting needle was approximately $20,000 per year (or approximately $73 per person).
Cost analysis: Cutting needle vs noncutting needle costs
DISCUSSION
We found that the rate of PLPH was significantly higher in our patient population with the use of a cutting needle (13%) as compared to what the expected rate would have been with a noncutting needle (4%). The rate of PLPH observed in this study is less than what has been previously reported in the literature but may have been due to underreporting of events. Patients may have stayed at home without seeking medical attention, may have consulted their own primary care physician, or may have gone to another hospital for emergency care. Further, we found that the costs associated with the use of a cutting needle (approximately $20,000 per year) were also significantly higher than what would have been expected with the use of a noncutting needle, despite higher initial costs associated with the purchase of a noncutting needle system.
This study highlights the potential importance of switching from a cutting to noncutting needle not only from the standpoint of patient care but also from the standpoint of cost. The costs estimated in this study were direct only, i.e., to patients and insurers. Indirect costs, e.g., the time spent by hospital personnel triaging patient phone calls (which was generated by 6% of all patients undergoing lumbar puncture in this study), time off work resulting in reduced productivity and wages, and time lost by family members transporting patients to the emergency department of office for headache treatment were beyond the scope of this study. Therefore, the costs estimated in this study are likely an underestimate of the true cost of an increased PLPH rate. Arendt et al.7 report that for every 6 patients having lumbar puncture with a noncutting needle, one will be spared a PLPH as compared with a cutting needle. A common misperception is that noncutting needles are more difficult to use. In fact, operator difficulty and failure rate are higher with cutting needles.8 Examples of noncutting needles include the Sprotte and Whitacre needles.9 These needles are readily available through various manufacturers. The technique of insertion differs from that of a cutting needle in that an introducer needle is used at the start of the procedure in order to puncture the skin.
In this cohort of patients, only younger age was an independent predictor of PLPH. Previous studies have identified younger age, female gender, and headache before or at the time of lumbar puncture as risk factors for headache.5 Lower body mass index and prior PLPH have been identified as possible additional risk factors. Class I and Class II data have not demonstrated that the duration of recumbency following a diagnostic LP influences the occurrence of PLPH. Further, there is no evidence that postprocedural hydration prevents PLPH. Despite its frequent use (and substantial cost), the practice of using IV caffeine for PLPH is not supported by well-designed clinical trials.10 In this study, aspirin use was not an independent predictor of absence of PLPH; however, the relatively few patients using antithrombotic agents may have obscured a true effect. Alternatively, aspirin use may have obscured mild PLPH. Further studies examining a possible relationship should be pursued.
The exact mechanism of PLPH is unknown. Possible explanations include persistent leakage of CSF from the puncture site, dilation of intracranial vessels, and psychological factors. Marshall11 performed lumbar punctures on 43 patients initially and 24 hours later. He found that although there was a tendency for PLPH to be associated with low CSF pressure, the relationship was not invariable nor was a low CSF pressure always associated with a headache. He suggested that a drop in a CSF pressure was not causal of the headache. Göbel et al.12 showed that patients with PLPH had higher right middle cerebral artery mean systolic flow velocities on TCD prior to lumbar puncture and lower mean systolic flow velocities in the right middle cerebral artery after lumbar puncture. They suggested that dilation of intracranial vessels may play a role in PLPH. Finally, Daniels and Sallie13 found that 46% of patients who were warned about PLPH developed one as compared to 6% who were not warned. They suggested that psychological factors may play a role. Noncutting needles offer the advantage of causing less CSF leakage than cutting needles14 although the precise mechanism of reduced PLPH is not completely known.
The limitations of this study include its retrospective design, the lack of an actual comparison group of patients undergoing lumbar puncture with a noncutting needle, and lack of information on indirect costs.
Further studies evaluating the adverse event rate and costs associated with switching to the noncutting system are warranted. In addition, further studies regarding the roles of aspirin around the time of lumbar puncture are warranted.
AUTHOR CONTRIBUTIONS
Statistical analysis was conducted by Michelle Jankowski.
DISCLOSURE
Dr. Dakka, Dr. Warra, Dr. Albadareen, and M. Jankowski report no disclosures. Dr. Silver serves on the editorial board of Stroke; has served as a consultant for Abbott Vascular, Inc.; and has provided expert testimony in medical malpractice defense cases related to stroke.
Footnotes
-
- AAN=
- American Academy of Neurology;
- LP=
- lumbar puncture;
- PLPH=
- post–lumbar puncture headache.
- Received September 11, 2010.
- Accepted December 22, 2010.
- Copyright © 2011 by AAN Enterprises, Inc.
REFERENCES
- 1.↵
- Corning JL
- 2.↵
- Quincke H
- 3.↵
- 4.↵
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(suppl 1):9–160.
- 5.↵
- Evans RW,
- Armon C,
- Frohman EM,
- Goodin DS
- 6.↵
- Armon C,
- Evans RW
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- Marshall J
- 12.↵
- 13.↵
- 14.↵
Letters: Rapid online correspondence
- Empirical Evidence for Non-Cutting Needles
- Leighanne R. McGill, Student, Mayo Cliniclrmcgill@live.unc.edu
- Kevin B. Boylan, MD
Submitted August 20, 2011 - re: Empirical Evidence for Non-Cutting Needles
- Brian Silver, bsilver@lifespan.org
- Brian Silver, Youssef Dakka, Nader Warra, Rawan J. Albadareen, Michelle Jankowski
Submitted August 20, 2011
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Cost comparison between the atraumatic and cutting lumbar puncture needlesChristie E. Tung, Yuen T. So, Maarten G. Lansberg et al.Neurology, December 28, 2011 -
Brief Communications
Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: A randomized trialR. Lavi, D. Yernitzky, J. M. Rowe et al.Neurology, October 23, 2006 -
Resident and Fellow Section
Education Research: Changing practiceResidents' adoption of the atraumatic lumbar puncture needleChristie E. Tung et al.Neurology, April 22, 2013 -
WriteClick: Editor's Choice
Headache rate and cost of care following lumbar puncture at a single tertiary care hospitalLeighanne R. McGill, Y. Dakka, Kevin B. Boylan et al.Neurology, November 28, 2011